Simcere Pharmaceutical Group Limited
27 OCT 2020
Simcere Pharmaceutical Group Limited is a company engaged in the R&D, production and commercialization of pharmaceuticals and currently is primarily focused on generic pharmaceuticals. Simcere has a diversified product portfolio in its strategically focused therapeutic areas, including oncology (including cell therapy), central nervous system diseases and autoimmune diseases. Simcere has established three R&D centers, and a national key laboratory of translational medicine and innovative pharmaceuticals. Simcere has been recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” and the “Top 100 Pharmaceutical Manufacturing Enterprises of China” for years.
先聲藥業集團有限公司是一家從事藥品研發、生產和商業化的公司，目前主要從 事仿製藥業務，在其專注的戰略性治療領域擁有多元化的產品組合，包括腫瘤疾 病（包括細胞治療）、中樞神經系統疾病及自身免疫疾病。公司已建立三個研發 中心，並建設轉化醫學與創新藥物國家重點實驗室，多年來位列「中國創新力醫 藥企業十強」和「中國製藥工業百強」。